Cited 0 times in
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.